Clinical Glomerulonephritis 3

8 Feb 2025 5:30 p.m. 6:30 p.m.

Amresh Krishna Moderator

Time	Session

12 a.m. 12 a.m.	RITUXIMAB MAINTENANCE THERAPY IS EFFECTIVE IN MAINTAINING REMISSION IN STEROID DEPENDENT AND FREQUENT RELAPSING ADULT NEPHROTIC SYNDROME WCN25-AB-156, Poster Board= SAT-126	2 CASES WITH IGM NEPHROPATHY WCN25-AB-2987, Poster Board= SAT-127	CLINICAL AND HISTOPATHOLOGICAL SPECTRUM OF KIDNEY BIOPSIES OF PATIENTS PRESENTING AS RAPIDLY PROGRESSIVE RENAL FAILURE (RPRF) – A SINGLE CENTRE OBSERVATIONAL STUDY WCN25-AB-186, Poster Board= SAT-128	PROSPECTIVE STUDY OF OUTCOMES IN LUPUS NEPHRITIS AMONGST ASIAN INDIANS: FIRST REPORT OF VNA:GNR LUPUS REGISTRY WCN25-AB-4376, Poster Board= SAT-129	NELL1-ASSOCIATED MEMBRANOUS NEPHROPATHY: A DETAILED CASE SERIES WITH CLINICAL, PATHOLOGICAL, AND IMMUNOLOGICAL INSIGHTS WCN25-AB-726, Poster Board= SAT-130	A COMPLEX CASE OF RENAL AMYLOIDOSYS: DIAGNOSTIC CHALLENGES IN A DEVELOPING COUNTRY WCN25-AB-319, Poster Board= SAT-131	LONG TERM RENAL OUTCOMES OF PATIENTS WITH MEMBRANOUS LUPUS NEPHRITIS ATTENDING A TERTIARY CARE CENTER OF NORTH INDIA WCN25-AB-3902, Poster Board= SAT-132	UNMASKING THE UNUSUAL: KIDNEY BIOPSY IN SYSTEMIC LUPUS ERYTHEMATOSUS WCN25-AB-1130, Poster Board= SAT-133	PULMONARY HEMORRHAGES IN A PATIENT WITH IG A NEPHROPATHY WCN25-AB-1964, Poster Board= SAT-134	ANTI-NEPHRIN ANTIBODIES IN ADULT CHINESE PATIENTS WITH MINIMAL CHANGE DISEASE AND PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS WCN25-AB-1675, Poster Board= SAT-135	THE ROLE OF NEUTROPHIL-LYMPHOCYTE AND PLATELET-LYMPHOCYTE RATIO AS A PREDICTOR OF RELAPSE IN LUPUS NEPHRITIS WCN25-AB-1185, Poster Board= SAT-136	CASE REPORT: TATTOO GIVING THE DIAGNOSIS OF RENAL SARCOIDOSIS WCN25-AB-539, Poster Board= SAT-137	"THE DUAL ANTIBODY DILEMMA: MANAGING SEVERE RPGN IN A 55 YEAR OLD WOMAN" WCN25-AB-1777, Poster Board= SAT-138	CLINICAL MANIFESTATIONS, MORPHOLOGICAL PATTERN AND TREATMENT OUTCOMES OF COMPLEMENT 3 GLOMERULOPATHY ON LONG TERM WCN25-AB-1260, Poster Board= SAT-139	GLOMERULAR DISEASE REGISTRY AND BIOBANK (GRIT)– DESIGN AND BASELINE RESULTS. WCN25-AB-1567, Poster Board= SAT-140	WHEN THE SPIKES ARE NOT MEMBRANOUS: AN UNUSUAL PRESENTATION OF FIBRILLARY GLOMERULONEPHRITIS WCN25-AB-1933, Poster Board= SAT-141	THE UNUSAL CASE SERIES OF PLA2R MEMBRANOUS NEPHROPATHY WITH PLA2R ANTIGEN ABSENT AND SERUM PLA2R ANTIBODY PRESENT WCN25-AB-1817, Poster Board= SAT-142	FELZARTAMAB REDUCES APLA2R AB BY SELECTIVELY DEPLETING CD38+ PLASMA CELLS AND PLASMABLASTS, THE MAIN PATHOGENIC CELLULAR DRIVERS OF DISEASE IN PRIMARY MEMBRANOUS NEPHROPATHY (PMN) WCN25-AB-843, Poster Board= SAT-143	FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IGA NEPHROPATHY (IGAN) WCN25-AB-318, Poster Board= SAT-144	ANTI-CD45 STAINING IN RENAL HISTOPATHOLOGY AS A PREDICTOR OF CLINICAL PRESENTATION AND SHORT-TERM OUTCOME IN LUPUS NEPHRITIS WCN25-AB-1101, Poster Board= SAT-145	OUTCOME OF USE OF ENTERIC RELEASED BUDESONIDE IN IGA NEPHROPATHY PATIENTS WITH NEPHROTIC AND SUBNEPHROTIC PROTEINURIA PRESENTATIONS: PROSPECTIVE COMPARATIVE STUDY IN TERTIARY CARE CENTRE WCN25-AB-4378, Poster Board= SAT-146	STEROID (SYSTEMIC OR ENTERIC RELEASED BUDESONIDE) REFRACTORY NEPHROTIC RANGE PROTEINURIA IN IGA NEPHROPATHY; CAN TACROLIMUS BE AN ALTERNATIVE?- A CASE SERIES WCN25-AB-932, Poster Board= SAT-147